+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modeling normal aging bone loss, with consideration of bone loss in osteoporosis

Modeling normal aging bone loss, with consideration of bone loss in osteoporosis

Toxicological Sciences 55(1): 171-188

A physiologically based model of normal bone loss in human aging is presented. The model is a modification of an existing physiologically based model of body and bone growth from birth to maturity. To account for loss of bone after peak bone mass is reached between ages 25 and 30 years, a slow first-order loss of bone is incorporated into the existing model. The rate constants for this first-order loss are the same for men and women but differ with the type of bone, being 3%/decade for cortical bone and 7-11%/decade for trabecular bone. In women, a 10-year period of more rapid loss of both cortical and trabecular bone is superimposed on the slow loss, beginning at the time of menopause. The superimposed loss occurs at the same relative rate in cortical and trabecular bone. Alterations in parameter values allow simulation of bone mass in osteoporotic men and women. The model is calibrated to quantitative estimates of cortical and trabecular bone mass as functions of age; in particular, to data sets of fractional vertebral bone volume as functions of age, and it is compared to the International Commission on Radiological Protection trend curves for skeletal mass in men and women to age 60. It is also applied to the question of whether loss of bone in women after menopause could create a hazard related to the return to blood of lead previously stored in bone. In agreement with observations made during 1976-1980, the model simulates an increase due to bone resorption of approximately 1 microg/dl in blood lead concentration in a postmenopausal (60-year-old) woman compared with a premenopausal (50-year-old) woman with typical lifetime ambient lead exposure.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010994197

Download citation: RISBibTeXText

PMID: 10788572

DOI: 10.1093/toxsci/55.1.171

Related references

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. Journal of Clinical Investigation 72(4): 1396-1409, 1983

Serum bone gla protein increases with aging in normal women implications for age related bone loss. Calcified Tissue Internationalppl. 1: S4, 1982

Microanatomical and histological changes associated with trabecular bone loss with aging and in osteoporosis. Bone 6(5): 416-416, 1985

Rates of bone loss in normal women evidence of accelerated trabecular bone loss after the menopause. European Journal of Clinical Investigation 18(5): 529-534, 1988

Primary osteoporosis. Methods to combat bone loss that accompanies aging. Postgraduate Medicine 93(8): 43-6 49-50 53-5, 1993

Severity and pattern of bone mineral loss in endocrine causes of osteoporosis as compared to age-related bone mineral loss. Journal of Postgraduate Medicine 62(3): 162-169, 2016

Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis. Endocrinology 159(1): 260-271, 2018

The mechanisms of bone mineral loss with aging: detection of pathological and physiological loss of bone mineral using single photon absorptiometry. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 24(2): 122-127, 1987

Bone turnover and bone loss in patients with hyperparathyroidism prediction of fast bone loss by quantitative bone scintigraphy. Journal of Nuclear Medicine 32(5 Suppl.): 982, 1991

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. Journal of Bone and Mineral Research 13(5): 763-773, 1998

Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?. Osteoporosis International 14(1): 27-33, 2003

Loss of trabeculae by mechano-biological means may explain rapid bone loss in osteoporosis. Journal of the Royal Society Interface 5(27): 1243-1253, 2008

Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis. Ugeskrift for Laeger 163(40): 5491-5495, 2001

The microanatomy of trabecular bone loss in normal aging men and women. Clinical Orthopaedics and Related Research 1987(215): 260-271, 1987

Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Current Osteoporosis Reports 7(4): 118-126, 2009